TIDMGWP

RNS Number : 9873N

GW Pharmaceuticals PLC

01 November 2016

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------------------- 
 a.   Name                            Mr James Noble 
---  ------------------------------  ----------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------------- 
 a.   Position/status                 non-executive Director/Deputy 
                                       Chairman 
---  ------------------------------  ----------------------------------------- 
 b.   Initial                         Initial notification 
       notification 
       /Amendment 
---  ------------------------------  ----------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------- 
 a.   Name                            GW Pharmaceuticals PLC 
---  ------------------------------  ----------------------------------------- 
 b.   LEI 
---  ------------------------------  ----------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------------- 
 a.   Description 
       of the                          Ordinary shares of 0.1p each ISIN: 
       Financial                       GB0030544687 
       instrument,                     Restricted American Depositary 
       type of                         Shares: ISIN: US36197T1372 
       instrument 
       Identification 
       code 
---  ------------------------------  ----------------------------------------- 
 b.   Nature of                      Conversion of 27,492 Ordinary shares 
       the transaction                into 2,291 Nasdaq listed Restricted 
                                      ADRs (12 to 1 Conversion ratio) 
---  ------------------------------  ----------------------------------------- 
 c.   Price(s)                         Price(s)   Volume(s) 
       and volume(s)                      -         2,291     ADSs issued upon 
                                                               conversion of 
                                                               27,492 Ordinary 
                                                               shares 
                                       ---------  ----------  ---------------- 
---  ------------------------------  ----------------------------------------- 
 d.        Aggregated 
            information 
             *    Aggregated volume                n/a 
 
 
             *    Price 
---  ------------------------------  ----------------------------------------- 
 e.   Date of                        31 October 2016 
       the transaction 
---  ------------------------------  ----------------------------------------- 
 f.   Place of                        New York 
       the transaction 
---  ------------------------------  ----------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFEALELLIIR

(END) Dow Jones Newswires

November 01, 2016 05:58 ET (09:58 GMT)

Gw Pharmaceuticals (LSE:GWP)
過去 株価チャート
から 5 2024 まで 6 2024 Gw Pharmaceuticalsのチャートをもっと見るにはこちらをクリック
Gw Pharmaceuticals (LSE:GWP)
過去 株価チャート
から 6 2023 まで 6 2024 Gw Pharmaceuticalsのチャートをもっと見るにはこちらをクリック